GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai Kehua Bio-engineering Co Ltd (SZSE:002022) » Definitions » Change In Receivables

Shanghai Kehua Bio-engineering Co (SZSE:002022) Change In Receivables : ¥0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2004. Start your Free Trial

What is Shanghai Kehua Bio-engineering Co Change In Receivables?

Shanghai Kehua Bio-engineering Co's change in receivables for the quarter that ended in Mar. 2025 was ¥0 Mil. It means Shanghai Kehua Bio-engineering Co's Accounts Receivable stayed the same from Dec. 2024 to Mar. 2025 .

Shanghai Kehua Bio-engineering Co's change in receivables for the fiscal year that ended in Dec. 2024 was ¥105 Mil. It means Shanghai Kehua Bio-engineering Co's Accounts Receivable declined by ¥105 Mil from Dec. 2023 to Dec. 2024 .

Shanghai Kehua Bio-engineering Co's Accounts Receivable for the quarter that ended in Mar. 2025 was ¥864 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Shanghai Kehua Bio-engineering Co's Days Sales Outstanding for the three months ended in Mar. 2025 was 203.35.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Shanghai Kehua Bio-engineering Co's liquidation value for the three months ended in Mar. 2025 was ¥611 Mil.


Shanghai Kehua Bio-engineering Co Change In Receivables Historical Data

The historical data trend for Shanghai Kehua Bio-engineering Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Kehua Bio-engineering Co Change In Receivables Chart

Shanghai Kehua Bio-engineering Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -324.90 -264.82 -407.28 271.54 105.03

Shanghai Kehua Bio-engineering Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Shanghai Kehua Bio-engineering Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Kehua Bio-engineering Co  (SZSE:002022) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Shanghai Kehua Bio-engineering Co's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=864.408/387.884*91
=203.35

2. In Ben Graham's calculation of liquidation value, Shanghai Kehua Bio-engineering Co's accounts receivable are only considered to be worth 75% of book value:

Shanghai Kehua Bio-engineering Co's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=787.588-1258.305+0.75 * 864.408+0.5 * 867.321
=611

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Kehua Bio-engineering Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Shanghai Kehua Bio-engineering Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Kehua Bio-engineering Co Business Description

Traded in Other Exchanges
N/A
Address
No. 1189 Qinzhou North Road, Xuhui District, Shanghai, CHN, 200233
Shanghai Kehua Bio-engineering Co Ltd is a developer, manufacturer, and marketer of in-vitro diagnostics business in China. Its products are mainly offered in two primary business segments: Diagnostic Reagents and Diagnostic Laboratory Instruments. Its products include diagnostic reagents, such as enzyme-immunoassay kits, clinical chemistry reagents, PCR kits, and rapid test kits and lab-instruments comprising chemistry analyzers, microplate washers/readers, electrolyte analyzers, and nucleic acid extractors.
Executives
Li Ming Executives
He Jian Wen Executives
Ji Yu Ming Supervisors
Li Ji Executives
Sha Li Wu Director
Wang Man Directors, executives
Tang Wei Guo Director

Shanghai Kehua Bio-engineering Co Headlines

No Headlines